Lv4
490 积分 2025-03-03 加入
Discovery of Potent Agonists for the Predominant Variant of the Orphan MAS-Related G Protein-Coupled Receptor X4 (MRGPRX4)
1个月前
已完结
Development of a clinically viable MRGPRX4 inverse agonist for cholestatic itch treatment
1个月前
已完结
Discovery of the First Raptor (Regulatory-Associated Protein of mTOR) Inhibitor as a New Type of Antiadipogenic Agent
1个月前
已完结
Introduction: T Cell Trafficking in Inflammation and Immunity
2个月前
已完结
Casticin reduces rosacea-related inflammation by inhibiting mast cell activation via Mas-related G protein-coupled receptor X2
2个月前
已完结
Luteolin Inhibits Ferroptosis of HUVEC by Regulating the Sirt1/Nrf2 Pathway
3个月前
已完结
Astragalin induces immunogenic cell death in liver cancer by targeting NQO2 to promote ROS-mediated endoplasmic reticulum stress pathway
3个月前
已完结
One-step bleaching method for animal fiber by persulphate/hydrogen peroxide: Degradation mechanism of eumelanin
3个月前
已完结
Thermal shift assays in drug discovery – Troubleshooting from biochemical to cellular applications
4个月前
已完结
OP0036 EFFICACY, SAFETY, AND PHARMACOKINETICS OF ANTI-CD40 ANTIBODY ABIPRUBART (KPL-404) IN PATIENTS WITH RHEUMATOID ARTHRITIS: A PHASE 2, RANDOMIZED, PLACEBO-CONTROLLED 12-WEEK-TREATMENT PROOF-OF-CONCEPT STUDY
5个月前
已关闭
皖公网安备34019202002308
